# Evaluation of Efficacy and Safety of Intella Dermal Filler in Moderate to Severe Nasolabial Folds

> **NCT07102537** · NA · COMPLETED · sponsor: **Espad Pharmed** · enrollment: 30 (actual)

## Conditions studied

- Nasolabial Fold Correction

## Interventions

- **DEVICE:** Hyaluronic acid combined with calcium hydroxyapatite injection

## Key facts

- **NCT ID:** NCT07102537
- **Lead sponsor:** Espad Pharmed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-02
- **Primary completion:** 2024-02-14
- **Final completion:** 2025-02-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07102537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07102537, "Evaluation of Efficacy and Safety of Intella Dermal Filler in Moderate to Severe Nasolabial Folds". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07102537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*